title: Adverse Reactions to Field Vaccination Against Lumpy Skin Disease in Jordan.
abstract: Lumpy skin disease (LSD) is an emerging disease in the Middle East region and has been recently reported in Jordan. The aim of this study was to investigate the adverse reactions that were reported after vaccine administration. Geographical areas enrolled in the study were free of the disease and away from the outbreak governorate. Sixty-three dairy cattle farms, with a total of 19,539 animals, were included in the study. Of those, 56 farms reported adverse clinical signs after vaccine administration. The duration between vaccine administration and appearance of adverse clinical signs ranged from 1 to 20 days (Mean = 10.3, SD ± 3.9). Clinical signs were similar to those observed with natural cases of lumpy skin disease. These were mainly fever, decreased feed intake, decreased milk production and variable sized cutaneous nodules (a few millimetres to around 2 cm in diameter) that could be seen anywhere on the body (head, neck, trunk, perineum), udder, and/or teats. Nodules were raised and firm initially and then formed dry scabs that could be peeled off the skin. The characteristic deep 'sit fast' appearance was rarely seen and most lesions were superficial. Some cattle had swollen lymph nodes, while a few pregnant animals aborted. The percentage of affected cattle ranged from 0.3 to 25% (Mean = 8, SD ± 5.1). Fever, decreased feed intake, and decreased milk production were seen in 83.9, 85.7, and 94.6% in cattle on the affected farms, respectively. All affected cattle displayed skin nodules over their entire bodies, while 33.9 and 7.1% of the affected farms reported nodular lesions present on the udders and teats, respectively. No mortalities were reported due to vaccine adverse reactions. Duration (course) of clinical signs ranged from 3 to 20 days (Mean = 13.7, SD ± 4.1). Two types of LSD vaccines were used by the farmers in this study. The first one was a sheep pox virus (SPPV) vaccine derived from the RM65 isolate [Jovivac, manufactured by Jordan Bioindustries Centre (JOVAC)] and the other an unlabelled one, which was later identified using PCR as a strain of lumpy skin disease virus (LSDV). Blood and skin samples collected from cattle vaccinated with the LSDV vaccine were positive for LSDV using both general and species-specific PCR primers, whereas those from cattle vaccinated with the Jovivac vaccine were negative. Adverse reactions observed in cattle after administration of the LSDV vaccine were reported to be more severe than those seen after Jovivac vaccine administration and were comparable with clinical signs observed in natural infections.
authors.affiliation: Department of Veterinary Clinical Sciences, Faculty of Veterinary Medicine, Jordan University of Science and Technology, Irbid, Jordan.|Veterinary Medicine Department, College of Food and Agriculture, United Arab Emirates University, Al Ain, UAE.
authors.forename: S M
authors.initials: SM
authors.lastname: Abutarbush
authors.affiliation: Department of Veterinary Pathology and Public Health, Faculty of Veterinary Medicine, Jordan University of Science and Technology, Irbid, Jordan.
authors.forename: W M
authors.initials: WM
authors.lastname: Hananeh
authors.affiliation: Department of Veterinary Clinical Sciences, Faculty of Veterinary Medicine, Jordan University of Science and Technology, Irbid, Jordan.
authors.forename: W
authors.initials: W
authors.lastname: Ramadan
authors.affiliation: Department of Veterinary Clinical Sciences, Faculty of Veterinary Medicine, Jordan University of Science and Technology, Irbid, Jordan.
authors.forename: O M
authors.initials: OM
authors.lastname: Al Sheyab
authors.affiliation: Department of Veterinary Clinical Sciences, Faculty of Veterinary Medicine, Jordan University of Science and Technology, Irbid, Jordan.
authors.forename: A R
authors.initials: AR
authors.lastname: Alnajjar
authors.affiliation: Department of Veterinary Clinical Sciences, Faculty of Veterinary Medicine, Jordan University of Science and Technology, Irbid, Jordan.
authors.forename: I G
authors.initials: IG
authors.lastname: Al Zoubi
authors.affiliation: The Pirbright Institute, Pirbright, Surrey, UK.
authors.forename: N J
authors.initials: NJ
authors.lastname: Knowles
authors.affiliation: The Pirbright Institute, Pirbright, Surrey, UK.
authors.forename: K
authors.initials: K
authors.lastname: Bachanek-Bankowska
authors.affiliation: The Pirbright Institute, Pirbright, Surrey, UK.
authors.forename: E S M
authors.initials: ES
authors.lastname: Tuppurainen
mesh_terms: D000818:Animals; D018151:Capripoxvirus / Q000276:immunology; D002417:Cattle; D005260:Female; D007597:Jordan / Q000453:epidemiology; D007775:Lactation Disorders / Q000209:etiology; D008166:Lumpy Skin Disease / Q000517:prevention & control*; D008877:Middle East; D016133:Polymerase Chain Reaction / Q000662:veterinary; D012871:Skin Diseases / Q000209:etiology; D014611:Vaccination / Q000009:adverse effects / Q000662:veterinary; D014613:Vaccines, Attenuated / Q000009:adverse effects / Q000276:immunology; D014765:Viral Vaccines / Q000009:adverse effects*
chemical_list: D014613:Vaccines, Attenuated; D014765:Viral Vaccines
keywords: Jordan; Middle East; cattle; emerging diseases; lumpy skin disease